Stevanato Group S.p.A. (STVN) Stock: Buy, Sell, or Hold?
STVN - Stevanato Group S.p.A.
$18.82
-0.19 (-1.00%)
▼
5d:
-2.54%
30d:
-13.27%
90d:
-2.99%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: STVN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: STVN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$32.19
Based on 11.5% avg growth
INTRINSIC VALUE TODAY
$19.99
5.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $18.82, which is considered oversold relative to its 30-day fair value range of $19.23 to $21.60. The stock's valuation (Forward PE: 22.7) is in line with its historical norms (22.7). At these levels, the market is pricing in 0.0% annual earnings growth.
Technical Outlook: Technically, STVN is in a uptrend. The price is currently testing key support at $18.51. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: STVN scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $24.47 (+30.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STVN is in a uptrend. The price is currently testing key support at $18.51. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: STVN scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $24.47 (+30.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$19.23 -
$21.60
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (83/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.0% below Wall St target ($24.47)
- BULLISH: Bottoming setup score 83/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$19.23 -
$21.60
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$18.51
Resistance Level
$19.82
Current Trend
Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.74
Wall Street Target
$24.47
(+30.0%)
Revenue Growth (YoY)
7.8%
Earnings Growth (YoY)
-26.5%
Profit Margin
11.0%
PE vs Historical
22.7 vs 22.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
0%
(market-implied from PE analysis)
1-Year Target
$18.82
(0%)
2-Year Target
$18.82
(0%)
3-Year Target
$18.82
(0%)
3-Yr Target (if PE normalizes)
(PE: 23→23)
PE COMPRESSION
$18.78
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.7, Growth: 19.0%)
$31.68
(+68%)
Base:
(SPY PE: 19.9, Growth: 19.0%)
$27.67
(+47%)
Bear:
(PE: 16.9, Growth: 19.0%)
$23.52
(+25%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 33.35 | Current EPS (TTM): $0.57
Bull Case
$30.36
(+61%)
Analyst growth 45.2%, PE expands to 36.7
Base Case
$27.60
(+47%)
Market implied 45.2%, PE stable at 33.4
Bear Case
$12.93
(-31%)
Severe decline -20.0%, PE contracts to 28.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 6:34 AM ET
Data refreshes hourly during market hours. Next update: 7:34 AM
Data refreshes hourly during market hours. Next update: 7:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 41 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 45 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 53 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$413 | 37 SELL |
|
WRBY
Warby Parker Inc |
STRONG BUY
14 analysts |
$30 | 57 HOLD |
